EUVIMEDDescoperă EUVIMED
KohortenstudieOpen access · CC BY 4.0

Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study

Erik Stenberg iD, Johan Ottosson, Yang Cao, Ida Lagstam, Erik Näslund

Obesity · 2025

DOI: 10.1002/oby.24318 ↗

At a glance

Kohortenstudie in Obesity, 2025. Written by Erik Stenberg and 4 co-authors. Institution: Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Major MEDLINE topics: Bariatric Surgery, Neoplasms. Cited 11 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Region Örebro County, Stockholm County Council, Strategic Research Programme in Diabetes.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Objective

Our objective was to evaluate how the incidence of cancer after metabolic and bariatric surgery (MBS) compared with the general population.

Methods

A nationwide cohort of patients who underwent MBS in Sweden from 2007 to 2020 were matched (age, sex, area of residence) to controls from the general population. All patients were followed for new incidence of cancer.

Results

Among the 68,424 patients who underwent MBS compared with the 640,944 controls, there was no difference in the risk for new onset of cancer (incidence rate ratio [IRR]: 1.03, 95% CI: 0.99–1.07). Compared with controls, MBS was associated with a lower risk for breast cancer in women (IRR: 0.78, 95% CI: 0.71–0.86) and nonmelanoma (IRR: 0.71, 95% CI: 0.59–0.85) and melanoma (IRR: 0.77, 95% CI: 0.68–0.87) skin cancer in men and women, but an increased risk remained for colon cancer, liver cancer, pancreatic cancer, corpus uteri cancer, renal cancer, malignant meningioma, and non‐Hodgkin's lymphoma.

Conclusions

All‐cancer incidence risk was similar between patients who underwent MBS and the general population. Although breast and skin cancer risk was lower among MBS patients compared with controls, MBS patients had a greater risk for multiple cancer types. Thus, patients who have undergone MBS should continue recommended cancer screening and clinically approved work‐up for cancer symptoms as recommended for the general population.

Subjects

MeSH terms (MEDLINE)

Bariatric SurgeryNeoplasmsHumansFemaleMaleSwedenMiddle AgedAdultIncidenceRisk FactorsCohort StudiesCase-Control StudiesAged

Authors and institutions

  • Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
  • Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.

ORCID profiles: Erik Stenberg

Funding

  • Region Örebro County
  • Stockholm County Council
  • Strategic Research Programme in Diabetes
  • Region Örebro län
  • Stockholm läns landsting

Cite

APA

Stenberg, E., Ottosson, J., Cao, Y., Lagstam, I., & Näslund, E. (2025). Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study. Obesity. https://doi.org/10.1002/oby.24318

Vancouver

Stenberg E, Ottosson J, Cao Y, Lagstam I, Näslund E. Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study. Obesity. 2025. doi:10.1002/oby.24318

BibTeX
@article{Stenberg2025,
  author = {Stenberg, Erik and Ottosson, Johan and Cao, Yang and Lagstam, Ida and Näslund, Erik},
  title = {Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study},
  journal = {Obesity},
  year = {2025},
  doi = {10.1002/oby.24318}
}
Start for free →